Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;31(5):e16248.
doi: 10.1111/ene.16248. Epub 2024 Feb 20.

Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database

Affiliations

Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database

Pietro Emiliano Doneddu et al. Eur J Neurol. 2024 May.

Abstract

Background and purpose: This study aimed to assess the diagnostic criteria, ancillary investigations and treatment response using real-life data in multifocal motor neuropathy (MMN) patients.

Methods: Clinical and laboratory data were collected from 110 patients enrolled in the Italian MMN database through a structured questionnaire. Twenty-six patients were excluded due to the unavailability of nerve conduction studies or the presence of clinical signs and symptoms and electrodiagnostic abnormalities inconsistent with the MMN diagnosis. Analyses were conducted on 73 patients with a confirmed MMN diagnosis and 11 patients who did not meet the diagnostic criteria.

Results: The European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) diagnostic criteria were variably applied.

Author: When applying the American Association of Electrodiagnostic Medicine criteria, an additional 17% of patients fulfilled the criteria for probable/definite diagnosis whilst a further 9.5% missed the diagnosis. In 17% of the patients only compound muscle action potential amplitude, but not area, was measured and subsequently recorded in the database by the treating physician. Additional investigations, including anti-GM1 immunoglobulin M antibodies, cerebrospinal fluid analysis, nerve ultrasound and magnetic resonance imaging, supported the diagnosis in 46%-83% of the patients. Anti-GM1 immunoglobulin M antibodies and nerve ultrasound demonstrated the highest sensitivity. Additional tests were frequently performed outside the EFNS/PNS guideline recommendations.

Conclusions: This study provides insights into the real-world diagnostic and management strategies for MMN, highlighting the challenges in applying diagnostic criteria.

Keywords: MMN; diagnosis; diagnostic criteria; guidelines; multifocal motor neuropathy.

PubMed Disclaimer

Conflict of interest statement

Pietro Emiliano Doneddu has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Fiore Manganelli reports personal fees for scientific events from CSL Behring and has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Dario Cocito has received honoraria for lecturing from Shire, CSL Behring and Kedrion and travel grants to attend scientific meetings from Shire, Kedrion and CSL Behring. Raffaella Fazio has served on scientific advisory boards for CSL Behring and has received travel grants from Kedrion and CSL Behring to attend scientific meetings. Marco Luigetti received financial grants from Ackea, Alnylam, Sobi and Pfizer, and travel grants from Ackea, Alnylam, Sobi, Pfizer, Kedrion and Grifols. Chiara Briani has served on scientific advisory boards for Pfizer, Alnylam and Akcea, and has received travel grants from Kedrion and CSL Behring to attend scientific meetings. Giovanni Antonini served on advisory boards and received travel grants from Alnylam, Alexion, UCB, Kedrion, and honoraria for lecturing from Kedrion. Anna Mazzeo has received travel grants from Kedrion and CSL Behring to attend scientific meetings. Massimiliano Filosto has served on scientific advisory boards for CSL Behring, Sanofi and Amicus and has received travel grants from Sanofi, Biogen, Kedrion and CSL Behring to attend scientific meetings. Giuseppe Cosentino has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Girolama Alessandra Marfia has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Maurizio Inghilleri has received travel grants to attend scientific meetings from CSL Behring and Alexion. Erdita Peci has received travel grants to attend scientific meetings from CSL Behring. Eduardo Nobile‐Orazio reports personal fees for advisory or scientific board from ArgenX (Belgium), Takeda (Italy and USA), CSL Behring (Italy and USA), Janssen (USA), Kedrion (Italy), LFB (France), Roche (Switzerland), Sanofi (USA). The other authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flowchart of the Italian MMN database. AAEM, American Association of Electrodiagnostic Medicine diagnostic criteria for MMN; EFNS/PNS, European Federation of Neurological Societies/Peripheral Nerve Society diagnostic criteria for MMN; MMN, multifocal motor neuropathy; NCS, nerve conduction studies.
FIGURE 2
FIGURE 2
Alluvial diagram illustrating the change in diagnosis using the EFNS/PNS and the AAEM diagnostic criteria for MMN in real life. AAEM, American Association of Electrodiagnostic Medicine diagnostic criteria for MMN; EFNS/PNS, European Federation of Neurological Societies/Peripheral Nerve Society diagnostic criteria for MMN; MMN, multifocal motor neuropathy.

Similar articles

Cited by

References

    1. Nobile‐Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve. 2005;31:663‐680. - PubMed
    1. Vlam L, van der Pol W‐L, Cats EA, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol. 2011;8:48‐58. - PubMed
    1. Yeh WZ, Dyck PJ, van den Berg LH, Kiernan MC, Taylor BV. Multifocal motor neuropathy: controversies and priorities. J Neurol Neurosurg Psychiatry. 2020;91:140‐148. - PubMed
    1. van Schaik IN, van den Berg LH, de Haan R, Vermeulen M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev. 2005;2:CD004429. - PubMed
    1. Umapathi T, Hughes R, Nobile‐Orazio E, Leger J. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev. 2015;3:CD003217. - PMC - PubMed

Substances

LinkOut - more resources